MedPath

Meiziya Kang M8 Capsules

Registration Number: MAL14075018TC

Approved
Approval ID

d3c6cc22002e5815

Registration Number

MAL14075018TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

28 CapsulesAvailable
Package Size: 28 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (10)

Nelumbo nuciferaActive
Ophiopogon japonicusActive
Monograph: ophiopogon japonicus
Rehmannia GlutinosaActive
Cynomorium songaricumActive
Monograph: cynomorium songaricum
Angelica sinensisActive
Cinnamomum cassiaActive
Monograph: cinnamomum cassia
Eucommia ulmoidesActive
Lycium barbarumActive
Monograph: lycium barbarum
Morinda officinalisActive
Monograph: morinda officinalis
Panax quinquefoliumActive
Monograph: panax quinquefolium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meiziya Kang M8 Capsules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform